The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ENLIGHTED phase 3 study: Interim results of efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) in the treatment of low-grade upper tract urothelial cancer (LG UTUC).
 
Vitaly Margulis
No Relationships to Disclose
 
Ronald Kaufman
No Relationships to Disclose
 
Gautier Marcq
Honoraria - Astellas Pharma; BMS Turkey; Janssen Oncology; Merck; Merck Serono
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology; MSD
Travel, Accommodations, Expenses - Astellas Pharma; Bouchara Recordati; Bristol-Myers Squibb; EDAP TMS S.A.; Ipsen; Janssen; MSD; MSD Oncology; Photocure
 
Asaf Shvero
No Relationships to Disclose
 
Neal Shore
Employment - GenesisCare
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Peerview; Pfizer; Photocure; PlatformQ Health; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow
 
Sarah Psutka
Leadership - Janssen
Honoraria - AstraZeneca
Consulting or Advisory Role - CG Oncology; ImmunityBio; Janssen; Merck
Research Funding - Janssen; Steba Biotech
Travel, Accommodations, Expenses - medtronic
 
Edward Uchio
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; CG Oncology; Dendreon; Janssen Oncology; Merck; Pfizer; Seagen
(OPTIONAL) Uncompensated Relationships - Astellas Pharma; AstraZeneca; Bayer; Genomic Health; Janssen Oncology; Lantheus Medical Imaging; Merck; Myriad Genetics; Pfizer
 
Hooman Djaladat
No Relationships to Disclose
 
Jay Raman
No Relationships to Disclose
 
Ahmad Shabsigh
No Relationships to Disclose
 
Marc Colombel
No Relationships to Disclose
 
Marcos Aller
No Relationships to Disclose
 
Steffen Rausch
Honoraria - Advanced Accelerator Applications; Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb/Sanofi; Ipsen; Janssen; Merck; Merck/Pfizer
Consulting or Advisory Role - Ambu; Bayer; Bristol-Myers Squibb/Sanofi; Eisai; Merck/Pfizer
Speakers' Bureau - Bayer
Research Funding - Ambu
Travel, Accommodations, Expenses - Bayer; ipsen; Janssen; Merck/Pfizer
 
Robert Grubb
No Relationships to Disclose
 
Axelle Mroz
No Relationships to Disclose
 
Natalia Kudinova
No Relationships to Disclose
 
Yaniv Cohen
No Relationships to Disclose
 
Genia Alpert
No Relationships to Disclose
 
Avigdor Scherz
No Relationships to Disclose
 
Jonathan Coleman
No Relationships to Disclose